Vanguard Group Inc Harrow Health, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Harrow Health, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,840,710 shares of HROW stock, worth $84 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,840,710
Previous 1,829,805
0.6%
Holding current value
$84 Million
Previous $24.2 Million
58.84%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding HROW
# of Institutions
129Shares Held
19.8MCall Options Held
700KPut Options Held
564K-
Opaleye Management Inc. Boston, MA3.99MShares$182 Million21.35% of portfolio
-
Private Capital Management, LLC Naples, FL2.71MShares$124 Million7.1% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$98.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA719KShares$32.8 Million0.0% of portfolio
-
State Street Corp Boston, MA715KShares$32.7 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.24B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...